Replies to post #12213 on Synaptogenix Inc (SNPX)

[Cyosol]

Maybe there is. Maybe there isn't.

The point is that this is a confirmatory trial meant to replicate the results that were already achieved in those non-memantine patients from the last trial. That does not mean there is a 98.8% probability of success.

The question is this:

If you give a larger group of patients not on memantine the same optimal dose as before, will they show an improvement similar to the smaller group from the last trial?